Literature DB >> 9129920

The role of ESWL in the treatment of calculi with anomalous kidneys.

B Semerci1, A Verit, O Nazli, O Ilbey, C Ozyurt, N Cikili.   

Abstract

OBJECTIVE: To evaluate the efficacy of Extracorporeal shock wave lithotripsy (ESWL) in renal anomalies.
MATERIAL AND METHODS: From 1991 to May 1995. 53 patients with calculi in anomalous kidneys presented to our clinic for treatment with ESWL. Average patient age was 39 years, a range of 6-66 years. These patients (32 male and 21 female) underwent ESWL treatments. ESWL was performed in 27 patients with urolithiasis in duplex system, 18 with horse-shoe kidneys, 4 with unilateral renal agenesis, 2 with pelvic ectopic kidneys, 1 with sigmoid kidney and 1 with L-shaped kidney.
RESULTS: Among patients who completed ESWL the rate free of stones was 60.4% and the rate of clinically insignificant residual fragments was 30.2%. No sign of stone disintegration was observed in 2 patients. They underwent open surgery. The shock waves per therapy varied between 811 and 18,101. Double-J stents were placed in 13 patients.
CONCLUSION: Most patients with calculi in anomalous kidneys can be managed primarily with ESWL.

Entities:  

Mesh:

Year:  1997        PMID: 9129920     DOI: 10.1159/000474472

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  ESWL in the treatment of stone in child with horseshoe kidney.

Authors:  A Slavkovió; M Vlajković; M Radovanović; Z Sirić; V Stefanović
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Extracorporeal shock wave lithotripsy in L-shaped kidneys: report of two cases.

Authors:  Hüsnü Tokgöz; Iker Sen; Mustafa Ozgür Tan; Metin Onaran; Hasan Biri; Ibrahim Bozkirli
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  A report of unusual crossed fused renal ectopia and minimal invasive management of calculi.

Authors:  Stéphane Larré; Xavier Carpentier; Philippe Sèbe; Marc Tassart; Olivier Cussenot; Olivier Traxer
Journal:  Surg Radiol Anat       Date:  2007-06-21       Impact factor: 1.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.